☰

Mary K. Pitner, Ph.D. - Publications

Affiliations: 
2013 Biological and Biomedical Sciences Emory University, Atlanta, GA 
Area:
Genetics, Molecular Biology, Cell Biology, Oncology
Tree Info Grants Similar researchers PubMed Report error

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Xie X, Chauhan GB, Edupuganti R, Kogawa T, Park J, Tacam M, Tan AW, Mughees M, Vidhu F, Liu DD, Taliaferro JM, Pitner MK, Browning LS, Lee JH, Bertucci F, et al. Correction: Maternal Embryonic Leucine Zipper Kinase Is Associated with Metastasis in Triple-negative Breast Cancer. Cancer Research Communications. 4: 236. PMID 38282551 DOI: 10.1158/2767-9764.CRC-24-0046  0.579
2023 Xie X, Chauhan GB, Edupuganti R, Kogawa T, Park J, Tacam M, Tan AW, Mughees M, Vidhu F, Liu DD, Taliaferro JM, Pitner MK, Browning LS, Lee JH, Shen Y, et al. Maternal Embryonic Leucine Zipper Kinase is Associated with Metastasis in Triple-negative Breast Cancer. Cancer Research Communications. 3: 1078-1092. PMID 37377604 DOI: 10.1158/2767-9764.CRC-22-0330  0.633
2020 Gagliardi M, Pitner MK, Park J, Xie X, Saso H, Larson RA, Sammons RM, Chen H, Wei C, Masuda H, Chauhan G, Kondo K, Tripathy D, Ueno NT, Dalby KN, et al. Differential functions of ERK1 and ERK2 in lung metastasis processes in triple-negative breast cancer. Scientific Reports. 10: 8537. PMID 32444778 DOI: 10.1038/S41598-020-65250-3  0.645
2019 Gagliardi M, Chauhan G, Pitner M, Iles L, Qi Y, Pusztai L, Tripathy D, Bartholomeusz G, Bartholomeusz C. Abstract P5-03-06: Overcoming MEK inhibitor resistance in triple-negative breast cancer by targeting myeloid cell leukemia-1 (MCL1), an anti-apoptotic protein Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-P5-03-06  0.603
2017 Pitner MK, Taliaferro JM, Dalby KN, Bartholomeusz C. MELK: a potential novel therapeutic target for TNBC and other aggressive malignancies. Expert Opinion On Therapeutic Targets. 1-11. PMID 28764577 DOI: 10.1080/14728222.2017.1363183  0.568
2017 Battula VL, Nguyen K, Sun J, Pitner MK, Yuan B, Bartholomeusz C, Hail N, Andreeff M. IKK inhibition by BMS-345541 suppresses breast tumorigenesis and metastases by targeting GD2+ cancer stem cells. Oncotarget. PMID 28415808 DOI: 10.18632/Oncotarget.16294  0.642
2016 Torres-Adorno A, Lee J, Kogawa T, Bartholomeusz C, Pitner M, Ordentlich P, Lim B, Tripathy D, Ueno N. Abstract P5-04-02: The histone deacetylase inhibitor entinostat enhances the efficacy of the MEK inhibitor pimasertib against aggressive types of breast cancer through Noxa-mediated myeloid cell leukemia 1 degradation Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P5-04-02  0.659
2016 Pitner MK, Saso H, Larson R, Sammons RM, Chen H, Wei C, Chauhan G, Kondo K, Ueno NT, Dalby K, Debeb BG, Bartholomeusz C. Abstract 1624: Silencing of ERK2 reverses EMT and suppresses the CSC phenotype, inhibiting lung metastasis in triple-negative breast cancer Cancer Research. 76: 1624-1624. DOI: 10.1158/1538-7445.Am2016-1624  0.674
2015 Kai K, Kondo K, Wang X, Xie X, Pitner MK, Reyes ME, Torres-Adorno AM, Masuda H, Hortobagyi GN, Bartholomeusz C, Saya H, Tripathy D, Sen S, Ueno NT. Antitumor Activity of KW-2450 Against Triple-Negative Breast Cancer by Inhibiting Aurora A and B Kinases. Molecular Cancer Therapeutics. PMID 26443806 DOI: 10.1158/1535-7163.Mct-15-0096  0.567
2015 Bartholomeusz C, Xie X, Pitner MK, Kondo K, Dadbin A, Lee J, Saso H, Smith PD, Dalby KN, Ueno NT. MEK inhibitor selumetinib (AZD6244; ARRY-142886) prevents lung metastasis in a triple-negative breast cancer xenograft model. Molecular Cancer Therapeutics. PMID 26384399 DOI: 10.1158/1535-7163.Mct-15-0243  0.672
Show low-probability matches.